Case Based DXA Discussions

Friday, March 31, 2023

3:45 PM – 4:45 PM

Location: Winnetka

*Speaker(s)

JC

John J. Carey, MBBChBAO, MS, CCD

Professor in Medicine
University of Galway, Ireland, Ireland

Disclosure(s): Abbvie, Ireland: Consulting Fee (e.g., Advisory Boards) (Terminated, January 30, 2023), Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Terminated, January 30, 2023); Amgen Ireland and Europe: Consulting Fee (e.g., Advisory Boards) (Terminated, January 30, 2023), Contracted Research (PI’s must provide disclosure in this category) (Terminated, January 30, 2023), Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Terminated, January 30, 2023); Eli Lilly, Ireland: Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Terminated, January 30, 2023); Nordic Pharma: Other (Terminated, January 30, 2023); Pfizer Ireland, UK, Europe, Brazil and Canada: Consulting Fee (e.g., Advisory Boards) (Terminated, January 30, 2023), Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Terminated, January 30, 2023)

Handouts

*Moderator(s)

Rachel Pessah-Pollack, MD, FACE (she/her/hers)

Clinical Associate Professor
NYU Langone Hospitals

Disclosure(s): BI/Lilly: Consulting Fee (e.g., Advisory Boards) (Ongoing); Health Monitor: Consulting Fee (e.g., Advisory Boards) (Ongoing)

Panelist(s)

Anita Colquhoun, RTNM, MRT(N), CDT

Charge Technologist
Women's College Hospital, Canada

-
Lawrence G. Jankowski, CBDT

Principle DXA Technologist
Illinois Bone and Joint Institute, LLC

-
Kyla Kent, BS

Technical Director for SAMBA Center at Stanford
Stanford Medicine

-
Manju Chandran, MD, FACP, FACE, FAMS (she/her/hers)

Senior Consultant and Director
Singapore General Hospital

-
Henrique Pierotti Arantes, CCD (he/him/his)

ISCD Latin America Panel
IMEPAC Araguari - Brazil, Brazil

Disclosure(s): No financial relationships to disclose
William Leslie, MD, MSc, CCD

Professor of Medicine and Radiology
University of Manitoba, Canada

-

Disclosure(s):

John J. Carey, MBBChBAO, MS, CCD: Abbvie, Ireland: Consulting Fee (e.g., Advisory Boards) (Terminated, January 30, 2023), Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Terminated, January 30, 2023); Amgen Ireland and Europe: Consulting Fee (e.g., Advisory Boards) (Terminated, January 30, 2023), Contracted Research (PI’s must provide disclosure in this category) (Terminated, January 30, 2023), Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Terminated, January 30, 2023); Eli Lilly, Ireland: Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Terminated, January 30, 2023); Nordic Pharma: Other (Terminated, January 30, 2023); Pfizer Ireland, UK, Europe, Brazil and Canada: Consulting Fee (e.g., Advisory Boards) (Terminated, January 30, 2023), Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Terminated, January 30, 2023)

Rachel Pessah-Pollack, FACE: BI/Lilly: Consulting Fee (e.g., Advisory Boards) (Ongoing); Health Monitor: Consulting Fee (e.g., Advisory Boards) (Ongoing)

Henrique P. Arantes, CCD: No financial relationships to disclose

Case based approach encourage the clinician to focus on examples where they can teach techs what clins want to see in their scans or common errors to avoid.

Learning Objectives:

Discuss complicated cases and how they should be analyzed.
Identify strategies for trouble-shooting problematic patient situations in metabolic bone.
Compare and contrast ideologies between different experts in the field.